Accuvest Global Advisors Bristol Myers Squibb CO Transaction History

Accuvest Global Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $9,929 - $14,430	-214 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$49.21 - $64.19 $1,673 - $2,182	-34 Reduced 13.71%	214 $14,000
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $10,606 - $12,576	248 New	248 $13,000
Q3 2019 Nov 06, 2019	SELL	$42.77 - $50.71 $619,566 - $734,585	-14,486 Closed	0 $0
Q2 2019 Jul 17, 2019	BUY	$44.62 - $49.34 $646,365 - $714,739	14,486 New	14,486 $657,000

Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $629,345 - $816,109	-12,907 Closed	0 $0
Q3 2018 Oct 31, 2018	SELL	$55.19 - $62.25 $226,223 - $255,162	-4,099 Reduced 24.1%	12,907 $801,000
Q2 2018 Aug 08, 2018	BUY	$50.53 - $62.98 $859,313 - $1.07 Million	17,006 New	17,006 $941,000
Q4 2017 Jan 30, 2018	SELL	$59.94 - $65.35 $5,094 - $5,554	-85 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $4,694 - $5,417	85	85 $5,000

2,553

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Accuvest Global Advisors, based on Form 13F filings with the SEC.

Stay updated on Accuvest Global Advisors with notifications on news.